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Résumé 
Introduction: Les troubles respiratoires du sommeil (TRS), qui représentent une 
préoccupation croissante pour la santé, ont des effets significatifs sur la santé, le 
comportement et la performance académique chez l’enfant. Les malformations 
craniofaciales, l’hypertrophie adéno-amygdalienne et l'obésité, représentent des facteurs de 
risque importants dans le développement de cette condition. Les symptômes des TRS ont été 
étudiés dans une étude prospective chez les enfants et adolescents durant leur traitement 
orthodontique dans un milieu universitaire. Cette étude a cherché à décrire la prévalence et 
les facteurs de risque principaux des TRS, ainsi que l'impact des différentes interventions 
orthodontiques sur les symptômes TRS.  
Matériel et méthodes: dans une étude cohorte prospective, un groupe de 168 sujets 
âgés de 12 à 21 ans ont été soumis, quatre ans après la prise de données initiale, à un examen 
craniofacial en plus d'être administré des questionnaires qui ont recueilli des données sur la 
situation socio-démographique, le bruxisme et les troubles d’ATM, le sommeil et le 
comportement diurne, et les facteurs neuropsychologiques.  
Résultats: l'indice de masse corporelle a été augmenté mais est demeurée dans la 
même catégorie aux deux moments de l'enquête. Il ya eu une augmentation du serrement des 
dents et des symptômes de l'ATM, une diminution de la taille des amygdales, et une 
augmentation de la somnolence diurne. La prévalence des TRS n'a pas changé entre l’étude 
initiale et l’étude de suivi. Aucune intervention orthodontique s'est avérée avoir un effet 
cliniquement significatif sur les voies aériennes supérieures.  
Conclusions: la prévalence des symptômes TRS était constante par rapport aux 
valeurs de base pour la population étudiée, mais a augmenté si rapportée à la population 
générale. Les traitements orthodontiques ne montrent aucun effet sur les TRS.  
Mots-clés : apnée du sommeil, craniofacial, prévalence, ronflement, traitement 
orthodontique, voies aériennes supérieures 
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Abstract 
Introduction: Sleep-disordered breathing (SDB), a growing health concern, has 
significant effects on a child’s health, behaviour, and scholastic performance. Craniofacial 
malformations, along with adenotonsillar hypertrophy and obesity, represent important risk 
factors in the development of this condition. SDB symptoms in children and adolescents 
followed for orthodontic treatment in a university setting have been investigated in this 
prospective study. The aims of this study were to describe the prevalence and main risk 
factors of SDB and the impact of different orthodontic interventions on the SDB symptoms.  
Materials and methods: in a prospective cohort study, four years following an initial 
evaluation, a group of 168 subjects aged 12-21 years underwent a craniofacial examination 
in addition to being administered self-completed questionnaires that collected information on 
socio-demographic and psychosocial factors, bruxism and temporo-mandibular joint (TMJ) 
disorders, sleep and daytime behaviour, and neuropsychological factors. 
Results: Body mass index (BMI) was slightly increased but remained in the same 
category at the two time points of investigation. There was an increase in tooth clenching 
and TMJ symptoms, a decrease in tonsils’ size, and an increase in daytime sleepiness. 
Prevalence of SDB did not change between baseline and follow-up studies. No orthodontic 
treatment intervention proved to have any clinically significant impact on the upper airway.  
Conclusions: SDB symptoms prevalence was constant when compared to the 
baseline values for the studied population, but increased if reported to the general 
population. Regular orthodontic treatment didn’t show any effect on SDB symptoms. 
 
Keywords : craniofacial, orthodontic treatment, prevalence, sleep apnea, snoring, upper 
airway 
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1 Chapter 1 
1.1 Introduction 
Sleep-disordered breathing (SDB) represents a growing health concern. It comprises 
a group of disorders distinguished by abnormal respiration during sleep. These cessations in 
breathing rhythm (called apneas) or sustained reductions in the breath amplitude 
(hypopneas) can cause arterial hypoxemia and hypercapnia, transient arousals from sleep 
and sleep fragmentation throughout the night, with a variety of consequences on daily 
activities and overall health of the individuals.  
1.2 Literature and methodology review 
1.2.1 Historical perspective 
Although the relationship between breathing and sleep has only recently been 
investigated by the medical community, excellent literary descriptions of what we know now 
to be the sleep apnea syndrome were made long ago. Obstructive sleep apnea (OSA) 
syndrome was described in 1836, not by a clinician but by the novelist Charles Dickens. In a 
series of papers entitled the “Posthumous Papers of the Pickwick Club” Dickens described 
Joe, a boy who was obese, a loud snorer, and always excessively sleepy. The first 
electrophysiological sleep recordings of “Pickwickian” patients and the understanding of the 
syndrome as disordered breathing in sleep were made only decades later, during the late 
1950s and 1960s (Bickelmann et al., 1956). Extensive research has been conducted 
thereafter in the field of pathophysiology of sleep and breathing in the late 1970s through 
early 1980s, and subsequently a first population study has been conducted (the Wisconsin 
Sleep Cohort), showing a significant prevalence of sleep apnea in a middle-aged, nonclinical 
population (Young et al., 1993).  
2 
 
 
From the mid 1990s to the present, we witnessed an explosion of basic, clinical, and 
population research investigating the prevalence, causes, consequences, and treatment of this 
widespread sleep problem whose importance has only been recently appreciated. Given its 
high prevalence and potential carryover to daytime pathology, sleep apnea has provided 
great impetus to the growth of sleep medicine as a clinical and research specialty. Hundreds 
of sleep medicine clinics have been built throughout the western world during the past 
decades, with the majority of their business concerned with the diagnosis and treatment of 
sleep apnea.  It seems that the two main reasons for sleep apnea syndrome being overlooked 
for so long have been misdiagnosis of patients with sleep apnea as having narcolepsy and 
skepticism regarding the validity of excessive daytime somnolence (EDS) as a clinical sign. 
1.2.2 Classification of SDB 
Sleep-related breathing disorders correspond to a range of nonspecific respiratory 
disturbances during sleep, including snoring, hypopnea, upper airway resistance, and full-
blown apnea.  
Cessation of breathing during sleep can result from obstruction of the upper airway 
(obstructive apnea), absence of inspiratory effort (central apnea), or a combination of the 
two. The second edition of the International Classification of Sleep Disorders (ICSD-2) 
(American Academy of Sleep Medicine, 2005) classifies sleep-related breathing disorders 
into five categories: central sleep apnea syndromes, obstructive sleep apnea syndromes, 
sleep-related hypoventilation and hypoxemic syndromes, sleep-related hypoventilation and 
hypoxemic syndromes, and other sleep-related breathing disorders (Table I). 
1.2.3 Definitions  
In order to better understand the complex pathophysiologic mechanism of sleep-
related breathing disorders, more specifically OSA, some definitions are first presented.  
Apnea, literally, means “no breathing”. It represents a cessation of respiratory 
airflow that lasts 10 seconds or longer. Apnea can be a central event (when respiratory 
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efforts are absent), an obstructive event (when respiratory efforts are present), or a mixed 
event (initial central apnea followed by obstructive apnea).  
Table  I. Sleep-Related Breathing Disorders 
Central Sleep Apnea Syndromes 
Primary central sleep apnea 
Central sleep apnea due to Cheyne-Stokes breathing pattern 
Central sleep apnea due to high altitude periodic breathing 
Central sleep apnea due to a medical condition, not Cheyne-Stokes 
Central sleep apnea due to a drug or substance 
Primary sleep apnea of infancy 
Obstructive Sleep Apnea Syndromes 
Obstructive sleep apnea, adult 
Obstructive sleep apnea, pediatric 
Sleep-Related Hypoventilation and Hypoxemic Syndromes 
Sleep-related nonobstructive alveolar hypoventilation, idiopathic 
Congenital central alveolar hypoventilation syndrome 
Sleep-Related Hypoventilation and Hypoxemia Due to a Medical Condition 
Sleep-related hypoventilation or hypoxemia due to pulmonary parenchymal or vascular 
pathology 
Sleep-related hypoventilation or hypoxemia due to lower airways obstruction 
Sleep-related hypoventilation or hypoxemia due to neuromuscular or chest wall disorders 
Other Sleep-Related Breathing Disorder 
Sleep apnea or sleep-related breathing disorder, unspecified 
(Courtesy of the American Academy of Sleep Medicine, Chicago, Ill.) 
Hypopnea is a reduction of respiratory airflow of at least 50% from baseline lasting 
at least 10 seconds, plus oxygen desaturation of at least 4%, caused by the lack of thoracic 
and abdominal effort (Madani and Madani, 2007a).  
Apnea-Hypopnea index (AHI) is the number of apneic plus hypopneic episodes that 
occur per hour during sleep and is used as a measure of the severity of sleep apnea.  
Respiratory effort–related arousal (RERA): A CNS arousal terminating 
obstructive breathing events that do not meet the criteria for apnea or hypopnea 
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Respiratory disturbance index (RDI): The number of apneas, hypopneas, and 
RERAs per hour of sleep. Unfortunately, the terms AHI and RDI are used interchangeably in 
much of the literature, and it is difficult to assess which abnormal breathing events have 
been scored. 
Somnolence represents the difficulty in maintaining alert wakefulness so that a 
person falls asleep if not actively aroused. 
Body Mass Index (BMI) is a measure of weight compared with height, calculated as 
weight in kilograms divided by height in meters squared. The categories of body mass index 
for adults are as follows (CDC, 2010): 
- Underweight: BMI <18.5 kg/m2         
- Healthy weight: BMI between 18.5 and 24.9 kg/m2 
- Overweight: BMI between 25 and 29.9 kg/m2 
- Obese: BMI over 30 kg/m2 
In growing children and adolescent patients, BMI is age-specific and sex-specific and 
are calculated using BMI-for-age curves. Using percentiles on such curves developed by the 
Center for Disease Control (Figures 1 and 2), the BMI-for-age weight status categories are 
as follows: 
- Underweight: 5th percentile 
- Healthy weight: 5th to 84th percentile 
- Overweight: 85th to 94th percentile 
- Obese: ≥95th percentile (Barlow, 2007) 
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Figure 1 BMI-for-age girls 2 to 20 years 
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Figure 2 BMI-for-age boys 2 to 20 years 
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Polysomnography (PSG) is a mechanical recording of a patient’s sleep using many 
criteria, such as the amount of oxygen in the bloodstream, pulse, brain waves, and eye 
movement, among others. PSG continuously and simultaneously records physiologic 
variables during sleep.  One can record EEG, EOG, EMG, ECG, airflow, snoring, thoracic 
and abdominal movement, and SaO2 using PSG. Other sensors that may be used during PSG 
include esophageal pressure monitors, PetCO2, PtcCO2, PAP level, additional EEG channels 
for evaluation of suspected nocturnal seizures, video-monitoring for evaluation of suspected 
parasomnias or seizures, and esophageal pH sensors for evaluation of suspected GER.  
PSG is indicated for diagnosis of SDB, PAP titration for SDB, follow-up after UA 
surgery or dental devices for OSA, diagnosis of narcolepsy and periodic limb movement 
disorder, evaluation of atypical or injurious parasomnias or of suspected nocturnal seizures.  
1.2.4 Epidemiology of SDB and the economic impact of sleep apnea 
The reported frequency of disordered breathing varies depending on the population 
studied, the methods used to detect apnea/hypopnea, or the threshold used to define 
abnormalities. Several epidemiological studies estimate that 2% to 5% of middle-aged adults 
are affected by OSA (Young et al., 1993), but many cases might actually be undiagnosed. 
Snoring, in contrast, is reported as affecting as much as 40% of the adult population (Kryger 
et al., 2005).  
Upper airway obstruction with snoring or obstructive sleep apnea is also frequently 
seen in children of all ages. Snoring is common, occurring in about 10-12% of young 
children (O'Brien et al., 2004), with a decreased frequency after the age of 9 years. 
Interestingly, the prevalence of snoring tends to increase threefold during pregnancy 
(Lavigne et al., 2009).  
A study conducted at the Université de Montréal on an orthodontic population 
reported that 10.9% of 13 year old children were usual snorers, 17.7% breathed heavily or 
loudly during sleep, and 5.3% were loud snorers, whereas observed apneas were noted in 
just 1.8% of patients (Morton, 2008). These results agree with those of other studies 
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investigating SDB in children (Gislason and Benediktsdottir, 1995;Redline et al., 1999). 
Childhood OSA has a minimum prevalence of 2 to 3% but some studies reported up to 10 to 
20% for habitual snoring children (Young et al., 2002). 
The American Academy of Sleep Medicine estimated that 25 million Americans 
suffer from sleep apnea and that 38,000 persons die each year from complications of sleep 
apnea (Madani and Madani, 2007b). As many as 2.5 million patients are investigated in 
sleep laboratories every year and at least half of them are treated by continuous positive 
airway pressure. The United States Department of Transportation reported that at least 
50,000 individuals each year are involved in motor vehicle accidents because of sleep apnea. 
Putting a dollar figure on everything, it is estimated that the minimum cost of sleep apnea to 
the US economy is $75 billion each year (Madani and Madani, 2007b). 
1.2.5 Anatomy and physiology of upper airway obstruction 
Upper airway (UA) airflow is determined by (1) the difference between upstream 
(i.e., nasal) and downstream pressure, and (2) airway resistance. As a result, airflow is 
greater with increased upstream pressure, decreased downstream pressure, and decreased 
airway resistance. 
The normal function of the UA requires the capacity for both patency and closure. 
Pharyngeal airway patency is maintained by a balance between the factors that maintain 
airway opening (e.g., action of the upper airway dilator muscles) and those that promote 
airway closure (e.g., negative intraluminal extrathoracic pressure, Bernoulli forces). Airway 
size is also influenced by lung volume, which decreases during sleep.  
The UA includes the extrathoracic trachea, larynx, pharynx, and nose. Of these, the 
pharynx is the only collapsible segment and can be divided into four sections (Figure 3.):  
A. the nasopharynx (from the nasal turbinates to the hard palate),  
B. the velopharynx (from the hard palate to the tip of the uvula),  
C. the  oropharynx (from the tip of the uvula to the tip of the epiglottis), and  
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D. hypopharynx (from the tip of the epiglottis to the level of the vocal cords). 
 
Figure 3 Segments of the upper airway as seen on midsagittal magnetic resonance imaging 
(adapted from Kryger’s Principles and Practice of Sleep Medicine, 5th edition) 
The most common site of UA collapse in OSA patients is the velopharynx or 
retropalatal region, although the collapse can extend to other sites or even begin at other 
locations within the upper airway (Lavigne et al., 2009). An additional site often cited as a 
primary narrowing location is the retroglossal region (Launois et al., 1993). However, most 
patients with OSA have more than one site of narrowing.  
Abnormal UA anatomy and possibly abnormal neural control during sleep can lead 
to pharyngeal airway collapse in patients with OSA, who have already been shown to have a 
narrowed, more collapsible pharyngeal airway. 
Repetitive UA obstruction due to reduced activity of UA dilating muscles during 
sleep is associated with: 
- episodic falls in SaO2 
- snoring (alternating with periods of silence) 
- arrhythmias (relative bradycardia during airway obstruction followed by 
tachycardia during termination of apnea) 
nasopharynx 
velopharynx 
oropharynx 
hypopharynx 
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- arousal at the termination of the event 
- increased BP in the immediate post-apneic period. 
1.2.6 Snoring  
Before the 1970s, snoring was thought to be simply an acoustic nuisance. Presently, 
with the understanding of snoring and obstructive sleep apnea as a continuum of sleep-
disordered breathing, its main clinical significance is that it is a marker of obstructive sleep 
apnea syndrome and upper airways resistance syndrome (Lugaresi et al., 1983).  
The ICSD defines snoring as a “respiratory sound generated in the upper airway 
during sleep that typically occurs during inspiration but may also occur in expiration.” 
(American Academy of Sleep Medicine, 2005) Snoring is not caused by any specific, 
localized abnormality within the airway; any membranous part of the upper airway that lacks 
cartilaginous support can vibrate (soft palate, uvula, faucial pillars, or pharyngeal walls). 
There are a number of alternate names for nonapneic snoring, including “primary snoring,” 
“simple snoring,” “benign snoring,” “habitual snoring,” and “heavy snoring.”  
The polysomnographic criteria to differentiate nonapneic snoring from snoring that is 
associated with adverse consequences are not yet fully defined. Nevertheless, there is a 
consensus that estimates that from the number of patients with habitual snoring, 
approximately 2-3% have clinically relevant disease, which, given the prevalence of 10 to 
20% for habitual snoring in children, brings us to a ratio of habitual snoring to OSA of about 
3:1 to 5:1 (Schechter, 2002). 
Snoring implies incomplete obstruction of the UA and patients who snore are 
considered to be at increased risk of cardiovascular disease, especially if snoring is 
associated with OSA. About 20% of patients who snore may also suffer from obstructive 
sleep apnea (Lavigne et al., 2009). Other commonly cited adverse health consequences 
associated with snoring are excessive daytime sleepiness (EDS) (Kryger et al., 2005) 
behavioural and cognitive deficits (attention, language, memory and executive function), and 
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mood disorders (O'Brien et al., 2004).  All children should be screened for snoring, given the 
gravity of health problems associated with this condition. 
Methods of measuring snoring vary, most often being a combination of objective 
sound measurements (maximum sound intensity, percentage of sleep time spent above a 
threshold level) and subjective assessment with questionnaires, preferably with input from 
the bed partner (Dalmasso and Prota, 1996). Snoring should be differentiated from OSA, 
UARS, or laryngospasm (Lavigne et al., 2009).  
1.2.7 Obstructive sleep apnea 
OSA represents a spectrum of disease, ranging from upper airway resistance 
syndrome (UARS) to OSA syndrome (Lavigne et al., 2009), which is the most common 
sleep-related breathing disorder and is considered a public health disease.  In adults, it is 
characterized by the repetitive, complete or partial, collapse of the pharyngeal airway during 
sleep and the need to arouse to restart ventilation. Sleep is thus disrupted, yielding waking 
somnolence and diminished neurocognitive performance. Pediatric sleep apnea is similar to 
its adult counterpart, but cortical arousals might not occur, possibly because of a higher 
arousal threshold (Kryger et al., 2005).  
In the current ICSD (2005), UARS is classified under OSA, although traditionally UARS 
was considered an intermittent form of SBD, between snoring and frank OSA (Figure 4.), 
characterized by a partial collapse of the upper airway, without the occurrence of obstructive 
apneas and hypopneas, or an AHI lower than 5 events per hour (Guilleminault et al., 1993). 
Only a polysomnographic examination can distinguish frank OSA from UARS. 
Pathogenesis of OSA 
The pathogenesis of OSA is not yet fully understood, but there are certain 
fundamental characteristics of respiratory airway modifications in patients with OSA which 
are well described in the literature. For instance, it has generally been shown that in OSA 
patients the size of the upper airway is smaller, rendering it more susceptible to collapse, and 
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the long axis of the upper airways tends to be oriented in an anteroposterior direction rather 
than laterally (Lavigne et al., 2009). The magnitude of the extraluminal pressure plays an 
equally important role in the collapsibility of the upper airway, and this is determined by the 
interaction of the volume of soft tissue within the upper airway and the size of the bony 
compartment. 
 
Figure 4. The spectrum of sleep disordered breathing (Kryger et al., 2005) 
Imaging studies using MRI, cephalometry or CT have shown that the volume of soft 
tissue structures is larger in OSA patients, whereas the bony structures tend to be diminished 
or retropositioned (smaller mandible, retropositioned maxilla, inferiorly positioned hyoid 
bone). It appears, therefore, that patients with OSA have anatomically compromised upper 
airways resulting from skeletal abnormalities, soft tissue abnormalities, or a combination of 
these factors (Ryan and Bradley, 2005).  
Several imaging studies have identified a number of craniofacial factors that can 
predispose individuals to compromised airway space and the development of OSA: 
- retruded maxilla and mandible in relation to cranial base 
- increased mandibular plane angle and anterior facial height 
- inferior displacement of the hyoid bone 
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- reduced length of the mandible 
- narrowed posterior airway space and longer soft palate 
- increased tongue size and/or 
- increased craniocervical angulation.  
In children, OSA is usually related to enlarged tonsils and/or adenoids, and more 
recently, with childhood obesity (Dayyat et al., 2009). In a study conducted at the 
Université de Montréal on a childhood orthodontic population, SDB symptoms have been 
primarily associated with adenotonsillar hyperthrophy, several craniofacial morphological 
characteristics (dolichofacial, high mandibular plane angle, narrow palate, severe crowding 
of the maxilla and mandible), allergies, frequent colds, and habitual mouth breathing 
(Morton, 2008). In this particular study, obesity per se was not shown to be related to an 
increased prevalence of SDB. Recent studies (Lee et al., 2010) also show a different balance 
between craniofacial structures and obesity in patients with OSA of different ethnicities, 
with increased obesity having a bigger impact on the severity of OSA for a Chinese 
population as compared to Caucasian populations. 
Reduced nasal breathing during wakefulness has long been related to craniofacial 
abnormality and a cause-and-effect relationship has been proposed (Linder-Aronson, 
1970;Woodside et al., 1991). Mouth breathing due to increased nasal resistance alters 
craniofacial growth thus increasing SDB severity. It has been demonstrated, in both animal 
and human studies, that mouth breathing leads to an altered pattern of muscle recruitment in 
the oral and nasal capsule, resulting in skeletal changes (Lavigne et al., 2009). Children with 
adenotonsillar hypertrophy and mouth breathing have an extended posture of the head, a 
retrognathic mandible, larger anterior facial height, steeper mandibular plane, lowered 
position of the hyoid bone, and anteroinferior posture of the tongue when compared to 
normal children (Woodside et al., 1991). 
The soft tissue stretch theory (Solow and Kreiborg, 1977), also developed in an 
attempt to elucidate the relationship between mouth breathing and craniofacial growth, 
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postulates that mouth breathing leads to postural changes (3-5° extended craniocervical 
posture), an altered pattern of muscle function, and concurrent skeletal changes. As the 
removal of the adenoids has been shown to reverse craniocervical angulation, increased 
nasal resistance has been been considered a trigger to the extended craniocervical posture.  
Recent reports from large epidemioligical studies (the Third National Health and 
Nutrition Examination Survey) conducted in the United States challenge these previously 
reported findings that showed a relationship between respiratory function and malocclusion 
(Lavigne et al., 2009). After controlling for age, race, gender, orthodontic treatment, and 
socioeconomic status, no significant difference has been found in the prevalence of 
respiratory disease and/or allergy in individuals with posterior crossbite, negative overjet, 
open bite, or excessive overjet compared to the prevalence in controlled subjects without 
these malocclusions. Further studies need to be conducted in order to elucidate this 
controversial issue. 
There is also a series of nonanatomic factors that are implied in the pathogenesis of 
OSA, and these are related to the activity of the pharyngeal dilator muscles and the central 
control of ventilation. Table II summarizes the anatomic and nonanatomic factors implicated 
in the pathophysiology of OSA.   
There is strong clinical evidence for a significant familial aggregation for symptoms 
of OSA in children and adults (Redline et al., 1994;Redline and Tishler, 2000;Taheri and 
Mignot, 2002). Genetics may determine upper airway anatomy, neuromuscular activity, 
ventilatory control stability, sleep-wake patterns, obesity predisposition, or can explain the 
occurence of OSA in particular ethnic groups. A brachycephalic head form, measured by 
anthropometry, is often found in association with reduced upper airway dimensions. This 
head form is also associated with a small but significant increased risk of OSAH in whites, 
and it also identifies families at risk for both OSAH and sudden infant death (Cakirer et al., 
2001). Genetic studies consistently estimate heritability for AHI to be between 35% and 
40% (Larkin et al., 2008). 
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Table II: Factors predisposing to collapse of the upper airway and  
the development of OSA 
Restriction in size of bony compartment 
Mandibular hypoplasia or retropositioned 
Maxillary hypoplasia or retropositioned 
Increase in soft tissue volume 
Deposition of fat around upper airway 
Macroglossia 
Enlargement of soft palate 
Thickening of lateral pharyngeal walls 
Adenotonsillar enlargement 
Pharyngeal inflammation and oedema 
Increase in pharyngeal compliance 
Decrease in pharyngeal dilator muscle activity 
Impairment of mechanoreceptor sensitivity 
Impairment of upper airway neuromuscular reflexes 
Impairment of strength and endurance of pharyngeal dilator muscles 
Decrease in lung volume 
Instability of ventilatory control 
Increase in surface tension 
Hormonal factors 
Presence of testosterone 
Absence of progesterone 
Endocrine disorders 
(Adapted from G. Lavigne et al, Sleep Medicine for Dentist, 2009 Quintessence Publishing) 
Risk factors for OSA 
The presence of certain risk factors can strengthen the clinical suspicion of OSA. The 
strongest risk factors are obesity and age older than 65 years (Grunstein et al., 1993). There 
has been shown to be an association between OSA and android-type obesity (fat deposition 
predominantly in the neck and abdomen), in contrast to the gynecoid-type obesity (with fat 
deposition in hips and legs) (Guilleminault et al., 1988). A positive family history increases 
the risk of sleep-disordered breathing by twofold to fourfold (Redline et al., 1995). Several 
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studies have shown that SDB is also exacerbated by alcohol ingestion, especially around 
bedtime.  
Additional risk factors include ethnicity, craniofacial abnormalities such as Marfan 
syndrome, Down syndrome, the Pierre-Robin syndrome, and other congenital craniofacial 
anomalies. Specific craniofacial and oropharyngeal features include: increased neck 
circumference (> 17 inches in men, >16 inches in women), nasal narrowing or congestion, 
macroglossia, low-lying soft palate, enlarged tonsils and adenoids (especially in children), 
mid-face hypoplasia, retrognathia, micrognathia or mandibular hypoplasia, and tracheal 
stenosis and laryngomalacia. 
Adenotonsillar enlargement represents the most important risk factor in children. 
However, size of the tonsils and adenoids is not predictive of OSA in individual patients. 
Other risk factors in children are a positive family history, excess body weight, chronic nasal 
obstruction (e.g., allergies, choanal atresia or stenosis), and craniofacial abnormalities 
1.2.8 Clinical signs and symptoms of SDB 
Patients with SDB manifest a variety of nocturnal and diurnal signs and symptoms 
(Table III). Almost all patients with OSA and many UARS patients snore. The bed partner 
usually reports chronic, heavy snoring, snorting, difficulty breathing during sleep, or 
witnessed breathing pauses through sleep.  
Excessive daytime sleepiness (EDS) is the most common complaint, but its severity 
doesn’t correlate closely with AHI. The manifestations of sleepiness can have subtle 
consequences (mid-afternoon drowsiness during a group meeting or an occasional nap), 
severe consequences (falling asleep while eating or talking), or catastrophic consequences 
(falling asleep while driving).  
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Table III: Clinical features of sleep apnea 
Daytime signs and symptoms Nocturnal signs and symptoms 
excessive daytime sleepiness snoring 
afternoon drowsiness snorting 
daytime fatigue witnessed apneas 
impaired concentration and attention awakening with a sensation of choking or gasping 
personality changes nocturnal gastroesophageal reflux 
morning headaches, migraine headaches restless sleep 
dry mouth or dry throat in the morning sweating during sleep 
myalgias Nocturia, enuresis 
postural hypotension bruxism 
dizziness  
(Adapted from Kryger,M., Roth,T., & Dement,W. Principles and practice of sleep 
medicine, 2005) 
Obesity is another hallmark of sleep apnea, especially increased neck circumference 
and central obesity. Although patients with OSA are usually obese older men, about 30% of 
patients with sleep apnea are nevertheless not obese (Malhotra and White, 2002) and the 
presence of other clinical signs and symptoms must trigger an OSA diagnosis. Hypertension, 
crowded pharynx, and retrognathia are also usual signs of SDB. 
Contrary to adult OSA, in children with sleep apnea the clinical features are less 
distinguished, with many signs and symptoms inconstantly present. EDS, for instance, is 
reported as being between 7% (Carroll et al., 1995) and 40%-50% (Chervin et al., 2006), 
depending on the type of questionnaire used to interogate subjects. EDS should be 
considered in any child older than 5 years of age who continues to nap during the day, 
especially if unplanned, or sleeps at least 2 hours more on weekends than on weekdays 
(‘weekend oversleep’).  
Other common EDS features in children are: 
- falling asleep at inappropriate times and situations 
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- behavioural problems (inattentiveness, irritability, hyperactivity or 
impulsiveness) 
- cognitive problems or academic difficulties 
- changes in mood (depression or anxiety) 
- fatigue and lethargy. 
Nevertheless, with an increased prevalence of pediatric obesity, we have witnessed a 
concomitant increase in childhood OSA, the clinical manifestations of which increasingly 
tend to resemble those of adult OSA. 
1.2.9 Diagnosis of SDB 
A variety of tools exist to evaluate SDB patients, including questionnaires, clinical 
examination, or diagnostic imaging, but the gold standard for the diagnosis of SDB is 
overnight polysomnography (PSG), that includes recordings of airflow, ventilatory effort, 
oxygen saturation, and body position, as well as ECG, EMG, and EEG. Given the need for 
the patient to spend a night in a sleep laboratory for a PSG recording and the expenses 
associated with that, more recently, home sleep-testing devices have been developed 
(Sunwoo and Kuna, 2010). These new devices are less sensitive than the attended laboratory 
PSG and are only indicated for patients with a high clinical suspicion for SDB.  
There are two schemes to assess severity of OSA. The more conservative one 
considers that for an adult an AHI of 5 to 20 is mild OSA, 21 to 50 is moderate, and more 
than 51 is severe OSA (Madani and Madani, 2007a). The second and more liberal one, 
which is more widely used, judges OSA as being mild for an AHI between 5 and 15 events 
per hour, moderate for AHI of 15-30 and severe for more than 30 obstructive breathing 
events per hour (Kryger et al., 2005). In children, an AHI of 1 event or more per hour of 
sleep is considered abnormal.  
Other factors that influence the clinical severity of OSA, apart from AHI, include the 
degree of EDS, the nadir of SaO2, the extent of sleep fragmentation, the presence of 
nocturnal arrhythmias, and the co-morbid cardiovascular or neurological disorders.  
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Lateral cephalometric radiographs, routinely used by orthodontists, have long been 
considered valuable diagnostic tools for the upper airway obstructions, as they can provide a 
good assessment of the skeletal and dental maxillary and mandibular relationships, as well as 
soft tissue relationships of the palate, tonsils, adenoids, and posterior pharynx. More 
recently, with the advent of the CBCT technology that provides a three-dimensional view of 
the upper airways, the shortcomings of previously used two-dimensional radiographs have 
been surmounted.  
Questionnaires are important in detecting possible sleep breathing disorders and a 
multitude of questionnaires have been developed for both adult and pediatric populations. 
Questionnaires such as the Berlin Questionnaire, the Pittsburgh Sleep Quality Index, the 
Epworth Sleepiness Scale, or the Sleep Apnoea Quality of Life Index are all validated 
screening instruments used for adults (Buysse et al., 1989a;Chasens et al., 2009;Chervin et 
al., 1997;Lacasse et al., 2002;Netzer et al., 1999;Sagaspe et al., 2010).  Pediatric sleep 
questionnaires (Acebo et al., 2005;Kushida et al., 2001;Montgomery-Downs et al., 2006) 
have also been developed and used in the past three decades, but low sensitivity and 
specificity have been noted related to OSA diagnosis, most probably caused by the difficulty 
of differentiating primary snoring from OSA (Carroll et al., 1995).  
Several studies questionned the validity of child sleep behaviour information 
provided by parents who do not necessarily share the room with their children (Chervin et 
al., 2007;Lumeng and Chervin, 2008); even so, given the expenses associated with SDB 
diagnosis based on PSG, questionnaires and clinical examinations remain the main 
instruments used for epidemiological screening of sleep disorders. 
1.2.10 Consequences of SDB 
There is an increasing body of evidence that points to OSA as a feature of the 
metabolic syndrome. The metabolic syndrome is a collection of closely related symptoms 
that together induce an increased risk of cardiovascular disease. Visceral obesity, 
hypertension, insulin resistance, hyperglycemia and dyslipidemia, are all symptoms of the 
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metabolic syndrome, with the visceral adiposity being considered the major determinant of 
this condition. Sleep fragmentation, common to OSA, has been linked to a decrease in 
insulin sensitivity (Tasali et al., 2008), whereas oxyhemoglobin desaturation has correlated 
with serum triglyceride and LDL cholesterol levels (Savransky et al., 2008).  
Patients with sleep apnea demonstrate variable degrees of neurocognitive 
deficiencies such as slowed thought processes, forgetfulness, delayed reaction time 
responses, and inability to concentrate. Both sleep fragmentation and its consequence of 
EDS have been invoked as causative factors of these neurocognitive impairments. EDS also 
has an impact on neurobehavioural performance, with many reports of OSA patients 
manifesting personality changes, irritability or aggressiveness.  
The major consequences of pediatric OSA involve neurobehavioural, cardiovascular, 
somatic growth, endocrine and metabolic systems. The criteria for the metabolic syndrome 
(insulin resistance, dyslipidemia, hypertension and obesity) are not yet entirely defined in 
children; nevertheless, increased evidence points to elevated circulation levels of leptin, an 
adipokine that regulates appetite, metabolic homeostasis, sleep, and respiratory control, in 
both adults and children (Tauman et al., 2007). Similar to adult OSA, pediatric OSA has 
now been associated with an increased risk for cardiovascular morbidities, although with a 
reduced severity of these manifestations (Bhattacharjee et al., 2009). However, it is 
anticipated that the frequency and severity of the cardiovascular consequences of pediatric 
OSA will be amplified by the simultaneous increase in obesity and diabetes among children.  
Sleep disruption through a period of rapid neurological development may also lead to 
important neurocognitive and behavioural deficiencies such as hyperactivity, poor school 
performance, learning or memory impairments, depression, mood changes, and overall 
problems with quality of life and self-esteem. 
1.2.11 Treatment of SDB 
Obstructive sleep apnea can be a lethal disease if not treated. There is increasing 
evidence showing an elevated risk of cardiovascular complications and death for patients 
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with moderate and severe OSA (Young et al., 2008), independent of age, sex, or obesity 
status, in particular for those who manifest both snoring and excessive daytime sleepiness 
(Lindberg et al., 1998).  
Treatment options for non-apneic snoring and OSA are basically similar, divided into 
nonsurgical and surgical approaches. Medical approaches, including risk modification 
(manipulation of body position during sleep; avoidance of alcohol and sedating 
medications), weight loss, and positive airway pressure (PAP) modalities are usually the first 
avenues of treatment. Patients who are unable or unwilling to comply with medical 
management may be candidates for surgery.  
CPAP therapy 
Continuous positive airway pressure (CPAP) is the gold standard of treatment for moderate 
to severe OSA; it may also be appropriate treatment for mild but symptomatic cases. 
Magnetic resonance imaging studies showed that CPAP increases airway volume and airway 
area and reduces lateral pharyngeal wall thickness and the upper airway edema that result 
from chronic vibration and occlusion of the airway (Schwab et al., 1996). Figure 5 shows the 
mechanism of UA occlusion and its prevention by nasal CPAP. When the patient is awake 
(left), muscle tone prevents collapse of the upper airway during inspiration. During sleep, the 
tongue and soft palate are sucked against the posterior oropharyngeal wall (middle). CPAP 
with low pressure provides a pneumatic splint and keeps the upper airway open (right).  
PAP therapy reduces mortality and sleepiness associated with OSA, increases sleep 
quality, and reduces the frequency of arousals, and increases the overall quality of life. The 
main limitations of CPAP use are the patient's acceptance and tolerance of treatment. 
Although the gold standard in treatment of adult OSA is CPAP, using nasal CPAP in 
children has proven to be extremely difficult, with a low rate of compliance (Marcus et al., 
2006). Moreover, extended use of nasal CPAP in growing individuals has been incriminated 
in mid-face hypoplasia (Abad and Guilleminault, 2009). The treatment of choice for 
pediatric OSA is tonsillectomy and adenoidectomy, with or without turbinate surgery, as the 
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hypertrophy of these structures is the primary cause of childhood SDB (Abad and 
Guilleminault, 2009). Children with craniofacial abnormalities resulting in maxillary or 
mandibular insufficiency may benefit from palatal expansion or maxillary/mandibular 
surgery. PAP therapy may be used for children who are not surgical candidates or if surgery 
fails.  
 
Figure 5. Mechanism of upper airway occlusion and its prevention by nasal continuous 
positive airway pressure (CPAP). Adapted from (Sullivan et al., 1981) 
Oral appliances 
Oral appliances are an established treatment option for snoring and mild obstructive 
sleep apnea–hypopnea in adults. It is a relatively simple and reversible approach to 
treatment. They appear to work by increasing upper airway space, stabilizing the anterior 
position of the mandible, advancing the tongue or soft palate, or both, and possibly by 
changing upper airway muscle activity.  
Most patients report improved sleep quality and less EDS with oral appliance 
therapy. Additionally, there is growing evidence of improvements in other important health 
outcomes, including neurocognitive function and cardiovascular health. Oral appliance 
therapy is generally well-tolerated, and short-term side effects are usually minor and are 
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related to excessive salivation, jaw and tooth discomfort, and occasionally joint discomfort. 
These symptoms usually improve over time. 
Children with OSA and a small and/or retrognathic mandible can benefit from 
treatment of their Class II malocclusion with orthopaedic appliances. Activator-headgear 
therapy followed by fixed appliance treatment has been shown to have the potential to 
increase pharyngeal airway dimensions and to maintain this change in UA on a long term 
basis, thus reducing the risk of developing long-term impaired respiratory function (Hanggi 
et al., 2008).  
Surgical therapy 
 Most common surgical interventions employed to provide or facilitate maintenance 
of a patent upper airway during sleep are tracheotomy, nasal reconstruction (septal or bony 
intranasal reconstruction, alar valve or alar rim reconstruction, and turbinectomy), 
uvulopalatopharyngoplasty (UPPP), tongue reduction, genioglossus advancement-hyoid 
myotomy and suspension (GAHMS), bimaxillary advancement, or maxillary and mandibular 
osteotomy (MMO). There are strict indications and contraindications for surgery for the 
OSA patient and they are listed in Table IV. 
Table IV. Indications and contraindications for Surgery in Sleep-Disordered 
Breathing 
Indications  Relative contraindications 
Excessive daytime sleepiness Morbid obesity 
Apnea–hypopnea index ≥ 20 Severe pulmonary disease 
Apnea–hypopnea index < 20 with severe 
excessive daytime sleepiness 
Unstable cardiovascular status 
Lowest sleep-related oxyhemoglobin saturation 
< 90% 
Psychological instability 
Diurnal hypertension or sleep-related arrhythmia 
or hypertension 
Alcohol or drug abuse 
Esophageal pressure more negative than −10 cm 
H2O 
Older age 
Anatomic airway abnormalities Unrealistic expectation of outcome 
Failure of medical management  
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When craniofacial disharmony is causative of sleep apnea or chronic snoring, 
maxillary and/or mandibular advancement surgery can be a valid treatment option. Maxillary 
advancement can be performed orthopedically (Kilinc et al., 2008) in a growing patient, or 
surgically in an adult patient. There are not many studies that investigated the effect of these 
two procedures on upper airway; there are reports (Samman et al., 2002) of increased 
nasopharyngeal depth following surgical advancement of the maxilla, but lack of controlled 
studies make such findings inconclusive.  
Surgical mandibular advancement is usually performed in conjunction with 
genioglossus advancement and addresses upper airway obstruction at the base of the tongue. 
It helps to stabilize the tongue base along with the associated pharyngeal dilatators.  
Maxillomandibular advancement (MMA) osteotomy is usually used for patients with 
significant OSA who cannot or will not use CPAP or who have frank mandibular deficiency. 
MMA is perhaps the most effective surgery for improving OSA when performed on 
appropriately selected patients. Studies report a reduction in the postoperative respiratory 
disturbance index (RDI) of at least 50%, with an average improvement of greater than 85%, 
in approximately 90% of patients (Won et al., 2008). 
Orthodontic therapy 
Given the common finding of craniofacial abnormalities in patients suffering from 
OSA, it has been hypothesized that improvement and normalization of the dentofacial 
complex may have an impact on respiratory problems and OSA. The three major anatomic 
regions of potential collapse during sleep in patients with SDB include the nose, palate, and 
tongue base. Each region can be surgically or orthopedically reconstructed on its own or in 
combination as necessary.  
A narrow maxilla has been associated with an increased prevalence of nasal 
obstruction and OSA symptoms in children. Maxillary constriction may increase nasal 
resistance and alter the tongue position, leading to narrowing of the retroglossal airway. 
Consequently, several studies have investigated the effects of maxillary expansion, a 
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common orthopaedic treatment for maxillary constriction, on the volume of the nasal cavity 
and as a result on OSA symptoms.  
It has been found that rapid palatal expansion (RPE) widens the nasal fossa and 
releases the septum (see Figure 6), thus restoring normal nasal airflow and resolving OSA in 
children with a case history of oral breathing, snoring and night time apneas (Pirelli et al., 
2005).  
 
 
 
 
 
 
Figure 6. Sutural opening after RPE. A, horizontal view: V-shaped opening of palatum 
durum after RME, with the rotational center near the third molar; B, Frontal view: V-shaped 
rotation of the maxilla after RME with the rotational center near the frontonasal suture. 
Adapted from (Deeb et al., 2010) 
Similar results have been documented in adults with narrow maxilla and OSA who 
had RPE or surgically assisted RPE (SARPE); major reductions in snoring, OSA, and EDS 
were found following these procedures (Cistulli et al., 1998). Conversely, a recent study 
(Langer et al., 2011) investigated the long-term effects of RPE on nasal resistance in 
children but couldn’t detect significant differences in nasal airway resistance 30 months after 
RME. As the long-term stability of the procedures that involve widening of the maxilla is 
questionable, further studies are needed to evaluate the consequent stability of respiratory 
improvements following RPE/SARPE. Moreover, a cause-and-effect relationship between 
OSA and the width of the naso-maxillary complex needs to be established. 
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Conversely, there are some orthodontic treatments routinely used by orthodontists 
that were incriminated in inducing or exacerbating SDB symptoms. Headgear therapy, for 
example, has been shown to possibly contribute to the occurrence of OSA when a strong 
predisposition, such as mandibular retrognatia, already exists (Godt et al., 2011;Pirila-
Parkkinen et al., 1999). Similarly, extraction treatment can be speculated to reduce available 
tongue space and consequently impinge on the upper airway, worsening SDB symptoms. A 
study has recently been designed (Valiathan et al., 2010) to evaluate the effect of four-
premolar extraction therapy versus non-extraction therapy on upper airways, but no 
statistically significant oropharyngeal airway volume changes were found between the two 
groups, despite expected changes in incisor angulations and position. 
Given the scarcity of, and sometimes contradictory results in the literature regarding 
the effects of common orthodontic therapy on SDB symptoms, further evidence and research 
is needed on the prevalence and evolution of SDB symptoms in orthodontic patients, as well 
as the impact of all orthodontic interventions on upper airways.  
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2 Chapter 2 
2.1 Rational and objectives 
An epidemiological study was conducted at the screening clinic of the graduate 
orthodontic department of the Université de Montréal on 604 subjects recruited between 
2006 and 2007 (Huynh N et al., 2011;Morton, 2008). The aims of that study were (1) to 
determine the prevalence of SDB and associated morphological and health-related factors in 
an orthodontic population and (2) to determine the relationship between patient 
characteristics implicated in reduced UA dimensions and OSA symptoms reported from a 
pediatric sleep questionnaire. 
The current study is established as a follow-up of the initial study conducted at the 
orthodontic screening clinic of the Université de Montréal.  
The aims of the present study were: (1) to describe the prevalence and main risk 
factors of sleep-disordered breathing (SDB) in children and adolescents having undergone 
orthodontic treatment, and to compare them with the baseline values; (2) to investigate to 
what extent different orthodontic treatment procedures affect the UA, influencing SDB 
symptoms; (3) to provide knowledge transfer by dissemination and communication to peer 
researchers through conference presentations and publications in peer-reviewed journals. 
In particular, we hypothesize that the prevalence of SDB symptoms do not change 
during childhood and adolescence, and that certain orthodontic interventions have an impact 
on the UA, influencing SDB symptoms in this particular population. 
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3 Chapter 3 
 
A previous study of our group investigated, in a cross-sectional manner, the 
prevalence of SDB symptoms and their associated craniofacial traits in a child and 
adolescent population seeking orthodontic treatment (Huynh N et al., 2011;Kryger et al., 
2005). The prevalence of these symptoms generally mirrored those previously reported in 
the literature. The craniofacial features that were identified as SDB risk factors by this study 
were the dolichofacial, high MPA, narrow palate, predominantly mouth-breathing patient, 
who also had severe crowding of the maxilla and mandible. In this particular population, 
obesity was not identified as a risk factor for SDB. 
After an interval of four years, a follow-up study was conducted and a subgroup of 
the initial population was subjected to the same investigations as in the baseline study. Most 
of the participant subjects have had an orthodontic intervention in the meantime, and are 
now in retention phase, or are still in an active phase of orthodontic treatment. The study, as 
well as the orthodontic treatment of the subjects, was carried out in the graduate orthodontic 
department of the Université de Montréal. 
Results of the aforementioned follow-up study are presented in the current thesis 
under the format of a manuscript in preparation for publication in the American Journal of 
Orthodontics and Dentofacial Orthopedics. 
 
 
 
 
 
 
29 
 
 
Manuscript in preparation to be submitted for publication in the AJODO 
 
Longitudinal evaluation of sleep-related 
breathing disorders in an orthodontic 
population 
Authors: 
Mandu-Hrit Ma,b, Huynh Na, Turkewicz Ja, Morton Pa, Papadakis Aa, Rompré PHa, 
Nicolau Bb 
aFaculté de médecine dentaire, Université de Montréal 
bFaculty of Dentistry, McGill University 
 
 
 
 
 
 
 
 
Copyright Manuela Mandu-Hrit, 2011 
30 
 
 
3.1 Abstract  
Introduction: Sleep-disordered breathing (SDB) has significant effects on a child’s 
health, behaviour, and performance. Craniofacial malformations represent important risk 
factors in the development of this condition. SDB signs and symptoms in children and 
adolescents followed for orthodontic treatment in a university setting have been investigated 
in this prospective study. The aims of this study were to describe the prevalence and main 
risk factors of SDB and the impact of different orthodontic interventions on the SDB 
symptoms for this specific population.  
Materials and methods: 168 subjects aged 12 to 21 years (mean age ± SD was 
16.48±2.19) underwent a clinical craniofacial examination in addition to being administered 
self-completed questionnaires that collected information on socio-demographic and 
psychosocial factors, bruxism and temporo-mandibular joint (TMJ) disorders, sleep and 
daytime behaviour, and neuropsychological factors. 
Results: Body mass index (BMI) was slightly increased but remained in the same 
category at the two time points of investigation. There was an increase in clenching and TMJ 
symptoms, a decrease in tonsil size, and an increase in daytime sleepiness. Prevalence of 
SDB was constant at baseline and follow-up studies. No orthodontic treatment intervention 
proved to have a statistically and clinically significant impact on upper airway.  
Conclusions: SDB signs and symptoms prevalence was constant when compared to 
the baseline values for the studied population, but increased when compared to the general 
population. Regular orthodontic treatment didn’t show any effect on SDB symptoms. 
Key words: craniofacial, orthodontic treatment, prevalence, sleep apnea, snoring, upper 
airway 
3.2 Introduction 
Sleep-disordered breathing (SDB) represents a growing health concern. Cessation of 
breathing during sleep can result from obstruction of the upper airway (obstructive sleep 
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apnea - OSA), absence of inspiratory effort (central apnea), or a combination of the two. 
Several epidemiological studies estimate that 2% to 5% of middle-aged adults are affected 
by obstructive sleep apnea (OSA) (Young et al., 1993), but many cases might actually be 
undiagnosed. Snoring, in contrast, is reported as affecting as much as 40% of the adult 
population (Kryger et al., 2005).  
Childhood OSA has a minimum prevalence of 2 to 3%, but some studies report up to 
10 to 20% for habitual snoring children (Young et al., 2002). A study conducted at the 
Université de Montréal on an orthodontic population found that 10.9% of 13 year old 
children were usual snorers, 17.7% breathed heavily or loudly during sleep, and 5.3% were 
loud snorers, whereas observed apneas were noted in just 1.8% of patients (Huynh N et al., 
2011;Morton, 2008). These results agree with those of other studies investigating SDB in 
children (Gislason and Benediktsdottir, 1995;Redline et al., 1999). Major consequences of 
pediatric OSA affect neurobehavioural, cardiovascular, somatic growth, endocrine and 
metabolic systems. 
Abnormal upper airway (UA) anatomy and possibly abnormal neural control during 
sleep can lead to pharyngeal airway collapse in patients with OSA, which have been shown 
to have a narrowed, more collapsible pharyngeal airway. Several imaging studies have 
identified a number of craniofacial factors that can predispose individuals to compromised 
airway space and the development of OSA: retruded maxilla and mandible in relation to 
cranial base, increased mandibular plane angle and anterior facial height, inferior 
displacement of the hyoid bone, reduced length of the mandible, narrowed posterior airway 
space and longer soft palate, increased tongue size, increased craniocervical angulation 
(Bixler et al., 2009;Huynh N et al., 2011;Riha et al., 2005).  
Adenotonsillar enlargement represents the most important risk factor in children. 
However, size of the tonsils and adenoids is not predictive of OSA in individual patients. 
Other risk factors in children are a positive family history, excess body weight, chronic nasal 
obstruction (e.g., allergies, choanal atresia or stenosis), and craniofacial abnormalities. A 
previous report by our research group demonstrated statistically significant associations 
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between clinical signs of malocclusion and reported symptoms of SDB. According to Huynh 
et al, 2011, a pediatric patient that is at increased risk of developing SDB is dolichofacial, 
has a high mandibular plane angle, a narrow palate, is predominantly a mouth-breather, and 
demonstrates severe crowding of the maxilla and mandible. 
Given the common finding of craniofacial abnormalities in patients suffering from 
OSA, it has been hypothesized that improvement and normalization of the dentofacial 
complex may have an impact on respiratory problems and OSA. Several studies 
demonstrated that rapid palatal expansion (RPE) widens the nasal fossa and releases the 
septum, thus restoring normal nasal airflow and resolving OSA in children with a case 
history of oral breathing, snoring and night time apneas (Pirelli et al., 2005). Conversely, 
there are some treatment regimens routinely used by orthodontists that were incriminated in 
inducing or exacerbating SDB symptoms. Headgear therapy, for example, has been shown to 
possibly contribute to the occurrence of OSA when a strong predisposition, such as 
mandibular retrognathia, already exists (Godt et al., 2011;Pirila-Parkkinen et al., 1999). 
Similarly, extraction treatment can be speculated to reduce available tongue space and 
consequently impinge on the upper airway, worsening SDB symptoms, although a recent 
study (Valiathan et al., 2010) found no statistically significant oropharyngeal airway volume 
changes between four-premolar extraction and non-extraction treatment groups, despite 
expected changes in incisor angulations and position. 
The current study is established as a follow-up of an initial study conducted at the 
orthodontic screening clinic of the Université de Montréal with the purpose of determining 
the prevalence of SDB and associated morphological and health-related factors in an 
orthodontic population and the relationship between patient characteristics implicated in 
reduced UA dimensions and OSA symptoms.  
The aims of the present study were: (1) to describe the prevalence and main risk 
factors of SDB in children and adolescents having undergone orthodontic treatment and to 
compare them with their baseline values and (2) to investigate how different orthodontic 
treatment procedures affect the UA. 
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3.3 Material and methods 
3.3.1 Study population  
The present study was of a longitudinal cohort design, representing the follow-up of 
an initial study conducted in 2006-2008 at the screening clinic of the graduate orthodontic 
program of the Université de Montréal (Huynh N et al., 2011;Morton, 2008). That study 
investigated 604 children and adolescents with respect to SDB prevalence and craniofacial 
risk factors of SDB. The study collected information on an array of social, psychological, 
life style and sleep quality and quantity parameters through the use of questionnaires 
completed by the patient and parent. A clinical head and neck examination was also 
completed with the goal of identifying upper airway and craniofacial abnormalities that may 
be related to SDB.  
For the present follow-up study 168 subjects responded to the invitation to participate 
and all were active or retention orthodontic patients still followed in the university 
orthodontic clinic. The study was conducted in accordance with the university’s ethical 
standards. All subjects and their parents or guardians gave their written consent to participate 
in the study. 
3.3.2 Instruments: questionnaires, clinical evaluation, and history of 
orthodontic treatment 
In the present study, participants underwent a clinical examination in addition to 
being administered self-completed questionnaires. The self-administered questionnaires 
collected updated information on socio-demographic and psychosocial factors, bruxism and 
TMJ disorders, sleep and daytime behaviour, as well as neuropsychological factors. All 
these questionnaires are routinely administered to the orthodontic patients and/or their 
parents at the Université de Montréal and they are modified and verified French translation 
of the: (1) medical and dental history questionnaire, (2) bruxism and TMD habits 
questionnaire, (3) sleep and daytime behavior (Pediatric Sleep Questionnaire), and (4) sleep 
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duration and quality (Pittsburgh Sleep Quality Index) (Blais et al., 1997;Buysse et al., 
1989b;Carrier et al., 2005). Most of the questions were of the dichotomous type (yes/no); in 
selected cases with multiple variables, the data was reduced into a dichotomous variable 
(e.g., “never” and “rarely” into “no”, and “often” and “always” into “yes”) 
All subjects also undertook a clinical head and neck examination with the goal of 
identifying features such as retrognathia, tonsillar hypertrophy, enlarged tongue or soft 
palate, and maxillary and mandibular retroposition, which can narrow upper airway 
dimensions and promote the occurrence of apneas and hypopneas during sleep. These 
measurements are also routinely registered for the patients treated in our orthodontic 
department. The standard orthodontic clinical evaluation was performed by an orthodontic 
resident (Manuela Mandu-Hrit) following a calibration session with the orthodontist that 
performed the clinical examination in the baseline study (Athena Papadakis). Details of the 
clinical examination performed were given in a previous publication of the same study group 
(Huynh N et al., 2011).  
We recorded the subject’s profile (convex, straight, or concave), facial frontal pattern 
(brachyfacial, mesofacial, or dolicofacial), mandibular plane angle, palatal vault shape, 
asymmetries of the dental midlines to the facial midline, type of respiration (mouth, nasal 
breathing, or both), tongue size,  and tonsil size according to the Brodsky scale (Brodsky, 
1989). TMJs and lateral mandibular movements were assessed, as well as the amount of 
overjet (OJ) and overbite (OB). The dental components of the malocclusion were evaluated 
clinically as molar and canine Angle classification, crowding of dental arches, curves of 
Spee and Monson. 
In addition to questionnaire-based investigation and clinical examination, we also 
collected data on the type of orthodontic treatment received by each subject in the study. We 
noted if the treatment involved extractions or not, and what kind of extractions (four 
premolar extractions, two upper premolar extractions, two lower premolar extractions, lower 
incisor extraction, or other extraction patterns); whether the treatment involved orthognathic 
surgery or not (mandibular advancement only in this sample population); if palatal 
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expansion (conventional or surgically-assisted) was part of the treatment; if the subject was 
wearing a head-gear appliance in addition to the standard fixed appliance treatment; or if a 
functional appliance to advance mandibular position was used. 
3.3.3 Data analysis 
As the clinical examination was performed by different investigators at the baseline 
study and the follow-up study (Athena Papadakis and Manuela Mandu-Hrit, respectively), 
interexaminer and intraexaminer agreement were calculated by kappa statistics on 
subsamples of 20 subjects. Kappa is a measure of agreement beyond that due solely to 
chance, where zero represents random agreement and 1.00 represents perfect agreement; 
0.40 and below represents poor agreement beyond chance, 0.40-0.75 represents fair to good 
agreement, and 0.75 and above represents excellent agreement (Fleiss and Chilton, 
1983;Hunt, 1986). 
Data are presented as mean ± the standard deviation (SD) for continuous variables 
and as percentages for categorical variables. Pearson’s χ2 Test and Ficher’s Exact test were 
used to evaluate the statistical relationships between clinical exam parameters and reported 
SDB symptoms. McNemar test was used to compare variables at the two time-point 
examinations, expressed as paired proportions.  
Student’s t tests for independent samples were used to compare continuous data 
between dichotomous sets. Statistical significance was assessed at p < 0.05. Data analysis 
was performed using SPSS version 15. 
3.4 Results 
3.4.1 Interexaminer and intraexaminer reliability 
For inter-examiner calibration, kappa values of 0.6 were obtained for profile and 
facial pattern assessment, and values of 0.8-0.9 for the rest of the measurements. Similarly, 
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kappa values for the intra-examiner agreement were in the range of 0.5 to 0.6 for profile and 
facial pattern evaluation, and 0.8 to 1.00 for the rest of the measurements.  
3.4.2 Demographic data 
One hundred and sixty eight subjects with a mean age of 16.94±3.44 years 
participated in this follow-up study, representing 27.8% of the initial sample in the baseline 
study. The gender distribution was 62.5% female and 37.5% male.  
According to the Center for Disease Control Body Mass Index for Age growth 
charts, the BMI scores indicated that 78.4% of the sample was considered of a healthy 
weight or underweight and 20.6% as overweight or obese. There was a slight increase in 
BMI between the two time points of evaluation, but the mean value remained in the same 
BMI category (Table V).  
3.4.3 Medical and dental history 
All subjects were in good health, as no major health issues were reported. 
Nevertheless, 31.6% reported suffering from allergies, which represents a 9.3% increase 
compared to the baseline values. Self-reported mouth-breathing was found in 19.1% of the 
subjects, whereas 56.9% asserted nose breathing. At the baseline study the respective values 
were 11.8% and 34.7%%, respectively, the calculated differences being statistically 
significant (p<0.05). 
 
Table V. Demographic data of the study group (n=168) 
Variable Baseline  Follow-up  
Age (mean±SD) 12.55±2.15 16.48±2.19 
BMI (mean±SD) 19.66±3.51 22.32±3.88 
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3.4.4 Bruxism and TMD 
According to the questionnaires, 17.5% of subjects manifested clicking sounds in 
their TMJ on opening or closing, 6% had episodes of closed lock mandible, and 9.7% 
revealed facial or masticatory muscle pain; all of these parameters showed statistically 
significant increases compared to the baseline assessments (Table VI). While 35.9% of 
interrogated subjects reported wake-time bruxism in this study, as compared to 12.6% in the 
baseline study (p=0.000), sleep bruxism (as evaluated by grinding teeth at night) didn’t have 
a statistically significant variation between the two time points of investigation (data not 
shown). 
Table VI. Reported bruxism and TMD habits from the Patient Questionnaire 
(n=166) 
Category Feature Baseline 
(%) 
Follow-up 
(%) 
p value 
TMD clicking sound on opening/closing 1.20 17.50 0.000 
 crepitus on opening/closing 3.60 5.40 0.607 
 closed lock 1.80 6 0.039 
parafunction clenching teeth 12.60 35.90 0.000 
 sleep bruxism 11.40 14.50 0.487 
 facial/masticatory muscle pain 4.20 9.70 0.078 
3.4.5 Sleep and daytime behaviour 
The prevalence data from the sleep questionnaire assessing SDB symptoms is found 
in Table VII. By combining snoring and breathing cessation during sleep, the result was that 
25.7% reported SDB symptoms, whereas 74.25% were free of symptoms; these proportions 
were similar to the baseline values (25.1% and 74.9%, respectively) for the same study 
group.  
By further analyzing this data, it was evident that the number of new subjects with 
SDB symptoms (n=21) was the same as the number of subjects that became free of SDB 
symptoms between the two time-points of analysis (n=21); furthermore, a number of 
subjects maintained their SDB symptoms (n=21), whereas the vast majority of subjects were 
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and remained free of symptoms at both times (n=103). Two subjects had incomplete data 
and were consequently excluded from this analysis. 
 
Table VII. Reported sleep and daytime behavior (n=168) 
Category Feature Baseline Follow-up p 
value
Snoring Frequency Usually Snores  8.90% 13.10% 0.189
 Always Snores  3% 1.80% 0.625
Snoring Quality Snores Loudly  4.80% 4.20% 1.000
 Heavy or Loud Breathing 15.50% 13.70% 0.743
Breathing Problems Trouble Breathing During Sleep 4.20% 7.20% 0.302
 Stop Breathing During the Night 1.20% 1.80% 1.000
Mouth Breathing Daytime Mouth Breathing 36.30% 32.70% 0.471
 Dry Mouth on Awakening 33.30% 35.70% 0.704
Daytime Sleepiness Feeling Unrefreshed in Morning 16.70% 31% 0.001
 Problem with Somnolence 7.70% 15.50% 0.024
 Sleepy as Reported by a Teacher 2.40% 7.80% 0.022
 Difficult to Awaken in Morning 21.40% 39.30% 0.000
Inattention/Hyperactivity Does Not Seem to Listen When 
Spoken To 
10.70% 13.10% 0.572
 Difficulty Organizing Tasks and 
Activities 
8.90% 10.10% 0.824
 Easily Distracted by External 
Stimuli 
23.80% 20.80% 0.56 
 Fidgets with Hands or Feet 19.80% 27.50% 0.117
 Agitated 5.40% 9.50% 0.167
 Interrupts or Intrudes on Others 9.50% 7.70% 0.648
 Poor Scholastic Results 3.80% 13.70% 0.002
Sleep duration Unable to fall asleep within 30 
min ≥3X/week 
10.20% 13.90% 0.8 
 Average hours of sleep per night 
(mean±SD) 
9:08±00:58 8:22±1:30 0.000
Sleep quality Poor overall sleep quality 3.60% 10.20% 0.000
Other Symptoms Morning Headache 2.40% 6.50% 0.092
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3.4.6 Orthodontic morphometric evaluation and craniofacial morphology 
The extraoral examination data revealed that the initial facial pattern, in terms of 
facial convexity, was preserved in most patients following orthodontic treatment (data not 
shown). Mandibular plane angle, as measured during the clinical exam, was found to be 
slightly increased compared to the baseline values, but the difference was not statistically 
significant (p=0.102). 
The baseline overjet and overbite values were reduced (from 4.40±0.2 mm to 
2.72±0.1 mm and from 3.89±0.14mm to 2.19±0.84 mm, respectively), as well as maxillary 
and mandibular crowding and the severity of the curves of Spee and Monson (data not 
shown).  
Enlarged tonsils were present in 8.3% of the subjects, compared to 15.5% in the 
baseline study (p=0.05), while 4.8% of the subjects reported having tonsillectomy or 
adenoidectomy. Prevalence of macroglossia was low (4.2%).  
Primary mouth breathing as assessed by the resident was present in 21.1% of the 
subjects, compared to 22.3% at the baseline study. Most of the study participants were nose 
breathers (59.6%), and the smallest group was mixed nose-mouth breathers (19.3%). 
3.4.7 Impact of orthodontic treatment on UA 
All study participants were active orthodontic patients in the department of 
orthodontics of the Université de Montréal or were in the retention phase of treatment for the 
past two years or less. They were all treated with fixed orthodontic appliances; 11% of the 
subjects were also treated with a headgear appliance, and 3% with ACCO, lip bumper, 
bionator, facemask, or twin block appliance.  The distribution of orthodontic treatment 
received by subjects of this study is given in Table VIII.  
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Table VIII. Distribution of orthodontic treatment procedures in the study population 
Treatment # of subjects Treatment # of subjects 
HeadGear 18 exo lower incisor 4 
RPE/SARPE 39 exo other 7 
orthognathic surgery 5 ACCO 3 
extractions 70 bionator 1 
exo 2 upper premolars 25 facemask 3 
exo 2 lower premolars 3 lip bumper 1 
exo 4 premolars 33 twin block 2 
In the subgroup of subjects that improved their SDB symptoms’ status (n=21) or 
manifested de novo SDB symptoms (n=21), each orthodontic treatment was presented as 
number of subjects per treatment type (Table IX). 
Table IX. Effect of individual orthodontic treatment on SDB symptoms  
Treatment Improved SDB 
symptoms (n=21) (%) 
De novo SDB symptoms 
(n=21) (%) 
Yes No Yes No 
HeadGear 1 (4.8%) 20 (95.2%) 2 (9.5%) 19 (90.5%) 
RPE/SARPE 6 (28.6%) 15 (71.4%) 4 (19%) 17 (81%) 
Orthognathic surgery 2 (9.5%) 19 (90.5%) 0 (0%) 21 (100%) 
Extraction treatment 9 (42.9%) 12 (57.1) 9 (42.9%) 12 (57.1%) 
Exo 2 upper premolars 3 (14.3%) 18 (85.7%) 1 (4.8%) 20 (95.2%) 
Exo 2 lower premolars 0 (0%) 21 (100%) 1 (4.8%) 20 (95.2%) 
Exo 4 premolars 4 ((19%) 17 ((81%) 5 (23.8%) 16 (76.2%) 
Exo lower incisor(s) 2 (9.5%) 19 (0.5%) 1 (4.8%) 20 (95.2%) 
Exo other 0 (0%) 21 (100%) 1 (4.8%) 20 (95.2%) 
3.5 Discussion  
A cohort study was designed at the Université de Montréal to evaluate the 
associations of SDB symptoms with facial/dental morphology in a general orthodontic 
population. The total number of the patients screened initially (i.e., in the baseline study) in 
the graduate orthodontic clinic was 604. Of these, 168 subjects responded to the follow-up 
call four years later, and they were given the same questionnaires that they and/or their 
parents responded to at the baseline study, in addition to having undergone a head and neck 
clinical examination.  
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The study population, with a mean age of 16.48 years and a female predominance 
(62.5%), mirrors that which is found in the general orthodontic population. Using BMI 
percentiles, the level of obesity was shown to be slightly increased compared to the initial 
examination, but the overall value remained in the same BMI category. These levels of 
adolescent obesity in our study follow the trend of increased obesity that has been reported 
worldwide over the past decades, and are comparable to the findings of Huh et al (Huh et al., 
2011), who reported a slight decrease in overweight individuals but an  increase in obesity 
throughout adolescence for a group of American females of European descent.  
Both sleep bruxism (SB) and tooth clenching (TC) or wake-time bruxism are 
common in the pediatric population. The prevalence of TC and SB in our sample reflects 
previous reports in the literature concerning both general (Ohayon et al., 2001) and 
orthodontic (Carra MC et al., 2011;Tecco and Festa, 2010) populations. TC has been shown 
(Magnusson et al., 2000) to have an increased prevalence in adolescents and young adults, as 
compared to SB, which is more prevalent in children ≤ 12 years of age. Our data mirror 
these findings. Similarly, TMJ problems showed an increase in the follow-up study 
compared to the initial study, which is in agreement with other reports (Kohler et al., 2009) 
that indicated a peak in TMD in adolescence and young adulthood.  
One of the objectives of the present study was to determine the prevalence of SDB 
symptoms in a subgroup (n=168) of this orthodontic population at a four-year interval, when 
most of the subjects were either in retention for a maximum of two years or in active 
orthodontic treatment. When combining snoring (“usually snores”, “always snores”, and 
“snores loudly”) with heavy breathing at night and respiratory cessation in sleep, the 
prevalence of SDB symptoms for the analyzed sample remained the same, with remission 
rates that equaled incidence rates. This finding endorses the observations of other studies 
that show that SDB prevalence doesn’t increase in children over the age of 9 until later in 
adulthood (Goodwin et al., 2010).  
Contrary to most reports of SDB prevalence in adolescence (between 3 and 12%), 
our study finds a prevalence of 25% of SDB symptoms (chronic or habitual snoring, 
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breathing arrest during sleep). The prevalence was also increased compared to that described 
by our group’s previous study (n=604), where 13.8% reported chronic or habitual snoring, 
and 1.8% reported breathing arrest during sleep (Morton, 2008).  One reason for this 
increased occurrence of SDB symptoms could be due to the selection bias, as subjects that 
responded to the follow-up study knew that they were participants in a sleep-related study. It 
might be that those that were aware of having sleep troubles were keener to continue to 
participate in a study that could eventually respond to their problems. 
A secondary objective of our study was to determine if changes in SDB status could 
be related to any type of orthodontic treatment, in accordance to several reports of 
orthopedic and orthodontic therapies that affect dento-facial morphology and thus SDB 
symptoms. Our results suggest that headgear treatment and orthodontic treatment that 
involves four premolar extractions could have a negative impact on the occurrence of SDB 
symptoms, whereas RPE/SARPE, orthognathic surgery (which in this context refers to just 
mandibular advancement) and other extraction patterns could offer a protective effect on 
SDB. However, the small number of cases in each treatment group prevents us from 
confidently affirming that the aforementioned treatment procedures have an effect on SDB. 
Moreover, the design of our study is not appropriate to infer a cause-and-effect relationship 
between orthodontic treatment and SDB symptoms. A larger study group will be necessary 
to draw better conclusions, and ideally randomized controlled studies should be designed to 
look into the effect of these orthodontic treatments on the UA patency. 
3.6 Limitations of the present study 
The study population of this investigation represents referred children seeking 
orthodontic care for esthetic and functional reasons, and this sample characteristic prevents 
generalizing the study results to a wider pediatric population. Orthodontic patients usually 
present malocclusions and craniofacial particularities that may render them prone to UA 
obstruction. Whereas the reported results might be representative for an orthodontic 
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population, more extensive studies investigating school-based samples could be of greater 
significance for a general pediatric population. 
Although questionnaires have been validated as useful to identify pediatric OSA, 
there are studies that demonstrated over-reporting of some symptoms when the 
questionnaires were administered to parents (Carroll et al., 1995;Kryger et al., 2005). 
Moreover, in our follow-up study some of the subjects responded to these questionnaires 
without having input from their parents, as opposed to the baseline study, where the same 
questionnaires were answered by parent/guardians and children. This might cast some doubt 
on the comparison of different variables at the two time points of the study. Conversely, 
being a prospective study where subjects were previously exposed to the same 
questionnaires and examination, it is our belief that investigated children were familiar with 
sleep-related questions and couldn’t err too much.   
Due to a relatively large sample size and lack of universal availability, a definitive 
diagnosis of OSA could not be made using the gold standard diagnostic tool, PSG. 
Ambulatory monitoring could have been a good substitute and should be considered in 
future studies. 
The design of the present study was not appropriate to establish a cause-and-effect 
relationship between the orthodontic intervention and the evolution of SDB symptoms. 
Although it is difficult to set one up, a randomized controlled study would ideally address 
this issue. In addition, given the diversity of the orthodontic treatment procedures used in 
this study, which consequently reduced sample size for each kind of treatment, statistically 
significant effects could not be confidently considered clinically significant. 
We consider this as a preliminary study that should prompt a more comprehensive 
study investigating the effects of various orthodontic treatment modalities on the upper 
airway patency. 
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3.7 Conclusions  
Pediatric SDB symptoms reported in this prospective cohort are primarily associated 
with craniofacial characteristics as opposed to obesity and tonsil size, and are constant for a 
four-year interval in the case of our study population, with remission rates that equaled 
incidence rates. Given the inappropriate sample size and study design, clinical significance 
of any specific orthodontic treatment on SDB symptoms could not be confidently 
determined.  
Orthodontists are in a privileged position to be able to recognize problems of SDB 
and direct patients towards diagnosis and treatment. Snoring in a child or adolescent requires 
further investigation for sleep apnea, as prevention and treatment for SDB diminishes the 
risk of serious health consequences and has the potential to improve a patient’s quality of 
life. 
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4 Chapter 4 
4.1 Summary  
This study has examined the prevalence of SDB symptoms in an orthodontic 
population and compared it to the one determined four years earlier. The sample subjects 
underwent orthodontic treatment in this time interval and at the time of the investigation they 
were either in orthodontic retention phase or in active orthodontic treatment.  
The administered questionnaires and the clinical craniofacial investigation permitted 
us to conclude that the prevalence of SDB symptoms did not change between the two time 
points of the investigation, with rates of remission that equaled incidence rates. This finding 
mirrors other reports in the literature that showed a high prevalence of SDB in children 
under 5 years of age, a remission or plateau for older children and adolescents, followed by a 
later increase in SDB prevalence in adulthood.   
The magnitude of SDB prevalence in our study sample was almost double the 
maximal values reported for the general population of similar age. One explanation for this 
difference can be found in the specificity of the investigated group, which was seeking 
orthodontic care and most likely has an increased prevalence of craniofacial features and 
dental malocclusions that can predispose to UA obstruction. The fact that the SDB 
prevalence also increased compared to the values reported in the baseline study, collected 
from a larger orthodontic population, suggests involvement of a selection bias, as the 
respondents to the follow-up study were probably more interested to participate in a study 
that could potentially solve their perceived problems. 
As mentioned earlier, the number of cases with de novo SDB symptoms equaled that 
of cases with remission of symptoms. By isolating these subsamples and looking more 
closely at the kind of orthodontic intervention these subjects received, we expected to be 
able to identify specific treatment types that are protective or inductive of SDB symptoms. 
Although statistic calculations isolated treatment options that might have had an effect on 
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UA, the small number of subjects in each treatment group prevented us from assigning 
clinical significance to our findings.  
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5 Chapter 5 
5.1 Conclusions and future research directions 
Results of the present study indicate a constant prevalence of OSA during the four-
year interval of the investigation. Nevertheless, there is an increased prevalence of SDB 
symptoms in the studied population compared to values reported in the literature. The 
reasons for this difference are not known, although some hypothesis can be advanced 
(orthodontic population vs. general population, selection bias). 
Craniofacial features were more associated with OSA symptoms than the presence of 
enlarged tonsils or increased obesity, and these results mirror those gathered in the baseline 
study. 
The diversity of orthodontic treatment solutions applied to a relatively small sample 
size prevented us from concluding that any specific orthodontic intervention is linked to 
protective or inductive effects on the UA. 
To overcome the drawbacks of the present study, more extensive prospective studies 
should be designed to investigate a larger population. This should not pose great problems in 
a university setting, where a large number of patients are treated and can be followed for 
several years. What can remain problematic, however, is the great variety of treatment 
philosophies and consequent treatment regimens administered to these patients when they 
are seen in a graduate orthodontic program by different residents supervised by different 
clinicians. Ideally, a randomized controlled trial (RCT) would be the design that would 
allow causality associations to be established. This is difficult to design and can pose ethical 
questions. 
In the past few decades, dentists have become more involved in certain aspects of 
OSA management, having an important role in screening, in referring for diagnosis and 
treatment, and in treating with the use of oral appliances or combined orthodontics and oral 
surgery. 
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The American Academy of Pediatrics (2002) recommends that children should be 
routinely screened for snoring and that symptomatic children should undergo PSG for 
diagnosis. Prevention and treatment for SDB diminishes the risk of serious health 
consequences (overall growth failure, restless sleep, impaired daytime function) and has the 
potential to improve a patient’s quality of life. Dentists in general and orthodontists in 
particular are in a privileged position to be able to recognize problems of SDB and to refer 
patients for diagnosis and treatment. 
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1.1. Appendix I : Patient Questionnaire (Medical, Dental, Habits, and Sleep) 
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QUESTIONNAIRE MÉDICAL ET DENTAIRE
Notez que le genre masculin est utilisé uniquement pour alléger le texte et inclut le féminin. 
 
Nom : __________________________ Prénom : __________________________ Sexe : F  - M  
Date de naissance : jour ____ mois ____ année ____ Âge : ____  
 
Histoire médicale : Oui Non 
Actuellement sous les soins d’un médecin?   
 Si oui, la raison :   
Prend des médicaments régulièrement?   
 Si oui, lesquels?   
Problème de saignement prolongé?   
Anémie?   
Haute/basse pression?   
Rhumes fréquents ou sinusites?   
Problèmes pulmonaires?   
Troubles digestifs?   
Diabète?   
Troubles thyroïdiens?   
Arthrite?   
Épilepsie?   
Troubles nerveux?   
Maux de tête fréquents?   
Perte de conscience?   
Maux ou limitation de mouvement au cou ou aux épaules?   
Maux d’oreilles?   
Chirurgie pour enlever les amygdales ou adénoïdes?     
Déjà eu radiothérapie (tumeur)?   
Allergies?   
 Fièvre des foins   
 Asthme   
 Poussière   
 Animaux   
 Autres   
 
Histoire dentaire :  Date du dernier examen dentaire : ____ mois ____ année 
Le patient a déjà eu : Oui Non 
 Traitements dentaires (gencives, traitement de canal, obturations)?   
 Traitements orthodontiques?   
 Extractions?   
Respire surtout : Par la bouche?   
 Par le nez?   
 Moitié par la bouche, moitié par le nez?   
Traumatisme : Sur les dents?   
 À la tête ou au cou?   
 Si oui, quel genre :   
Douleur : Aux gencives?   
 Aux dents?   
Déjà sucé son pouce/ses doigts?   
Suce encore son pouce/ses doigts?   
Troubles de la langue?   
Troubles de la parole?   
À déjà vu un orthophoniste?   
Le patient joue un instrument de musique? Si oui, lequel?  
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Habitudes : Oui Non 
1. Est-ce que l’articulation de la mâchoire du patient craque (fait des bruits secs) en ouvrant ou en 
fermant ou en mastiquant? 
  
2. Est-ce que l’articulation de la mâchoire du patient fait un bruit de grattement (frottement) en 
ouvrant ou en fermant ou en mastiquant? 
  
3. Est-ce que la mâchoire du patient se bloque de sorte que l’ouverture normale n’est pas possible?   
 Si oui, est-ce que c’est possible de la débloquer toute seul?   
 Si non, combien de temps le blocage dure généralement?   
4. Est-ce que la mâchoire du patient bloque de sorte que la fermeture normale n’est pas possible?   
5. Est-ce que le patient mastique ou suce : Jamais ou 
presque Parfois Souvent 
Toujours 
ou presque
 Ses lèvres, sa langue ou ses joues?     
 Ses ongles?     
 De la gomme à mâcher?     
 Un crayon ou un stylo?     
6. Est-ce que le patient serre les dents? Oui Non 
   
 
Jamais ou 
presque Parfois Souvent 
Toujours 
ou presque
 Si oui,     
 Pendant la journée?     
 Pendant la nuit?     
7. Est-ce que le patient grince des dents? Oui Non 
   
 Jamais ou 
presque Parfois Souvent 
Toujours 
ou presque
 Si oui,     
 Pendant la journée?     
 Pendant la nuit?     
 Est-ce que cela le dérange?     
  Si oui, pourquoi?     
 Oui Non 
8. Est-ce que ses dents sont usées?   
9. Est-ce que le patient a déjà brisé des plombages ou couronnes?   
10. Est-ce que la façon dont les dents ferment est inconfortable?   
 Sur le 
ventre Sur le dos Sur le côté 
Variable ou 
ne sais pas
11. En général, quelle est sa posture lors du sommeil?     
 Jamais ou 
presque Parfois Souvent 
Toujours 
ou presque
12. Est-ce que sa mâchoire est endolorie ou raide en se 
réveillant le matin? 
    
13. Est-ce que le patient ressent de la fatigue au niveau des muscles du visage ou de la 
mastication? 
Oui 
 
Non  
 
 Jamais ou 
presque Parfois Souvent 
Toujours 
ou presque
 Lors de son réveil le matin?     
 Pendant la journée?     
 Pendant la nuit?     
 Augmente Diminue Stable Variable 
 Comment cette fatigue varie-t-elle?     
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14. Au cours du dernier mois, 
indiquez jusqu’à quel point son 
problème de mâchoire rend 
difficile : Pas du tout Un peu Modérément Beaucoup Extrêmement
 Mastiquer      
 Boire      
 Exercices physiques      
 Manger des aliments durs      
 Manger des aliments mous      
 La digestion      
 Nettoyer les dents      
 Bâiller      
 Avaler      
 Parler      
 
Sommeil : Oui Non
1. Durant son sommeil, est-ce que le patient :   
 Ronfle plus de la moitié du temps?   
 Ronfle toujours?   
 Ronfle bruyamment?   
 Respire fort ou bruyamment?   
 A des problèmes ou de la difficulté à respirer?   
2. Avez-vous déjà vu le patient :   
 Arrêter de respirer durant la nuit?   
3. Est-ce que le patient :   
 A tendance à respirer par la bouche durant le jour?   
 Se réveille avec la bouche sèche?   
 Mouille son lit occasionnellement?   
4. Est-ce que le patient :   
 Se réveille avec un sentiment de ne pas être reposé?   
 A un problème de somnolence durant le jour?   
 Est-ce qu’un professeur ou une autre personne vous a rapporté que le patient somnole durant 
le jour? 
  
 Est difficile à réveiller le matin?   
 Se réveille le matin avec des maux de tête?   
 Grandit de façon normale depuis sa naissance?   
 Est obèse?   
5. Souvent, le patient :   
 Ne semble pas écouter lorsqu’on lui parle directement.   
 A de la difficulté à organiser des tâches et des activités.   
 Est facilement distrait par des stimulis externes.   
 Gigote ses mains ou ses pieds ou se tortille lorsqu’il est assis.   
 Ne reste pas en place ou est agité.   
Interrompt ou est intrusif avec les autres (exemple : se mêle d’une conversation ou d’un jeux 
sans y être invité) 
  
6. À l’école, le patient :   
 Réussit bien?   
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Qualité du sommeil : 
Instructions : Les questions qui suivent font références aux habitudes de sommeil du patient au cours du dernier 
mois seulement. Vos réponses devraient correspondre aux meilleures estimations possibles pour la majorité des 
jours et des nuits du dernier mois. SVP veuillez répondre à toutes les questions. 
1. Durant le dernier mois, à quelle heure vous êtes-vous couché? ________ 
2. Durant le dernier mois, combien de minutes avez-vous pris pour vous endormir à chaque soir? ______ min 
3. Durant le dernier mois, à quelle heure vous êtes-vous levé le matin? ________ 
4. Durant le dernier mois, combien d’heures de sommeil avez-vous eu par nuit? (ceci peut-être différent du nombre 
d’heures passées au lit) ______ heures 
5. Durant le dernier mois, combien de fois avez-vous 
eu de la difficulté à dormir parce que vous : 
Pas durant 
le dernier 
mois 
Moins 1 
fois par 
semaine 
1 ou 2 fois 
par 
semaine 
3 fois ou 
plus par 
semaine 
5.a Ne pouviez pas vous endormir à l’intérieur de 30 min?     
5.b Vous réveilliez au milieu de la nuit ou tôt le matin?     
5.c Deviez vous lever pour aller à la salle de bain?     
5.d Ne pouviez pas respirer facilement?     
5.e Toussiez ou ronfliez bruyamment?     
5.f Aviez froid?     
5.g Aviez trop chaud?     
5.h Aviez fait de mauvais rêves?     
5.i Ressentiez de la douleur?     
5.j Autres raisons. SVP décrivez et à quelle fréquence : 
 
    
Très bien Plutôt bien Plutôt mal Très mal6. Durant le dernier mois, comment évalueriez-vous la 
qualité globale de votre sommeil?     
7. Durant le dernier mois, combien de fois avez-vous : Pas durant 
le dernier 
mois 
Moins 1 
fois par 
semaine 
1 ou 2 fois 
par 
semaine 
3 fois ou 
plus par 
semaine 
7.a Pris un médicament (avec ou sans ordonnance) pour 
vous aider à dormir? 
    
7.b Eu de la difficulté à rester éveillé pendant que vous 
conduisiez, mangiez, ou vous engagiez dans une activité 
sociale? 
    
Aucune Légère 
Quelque 
peu Beaucoup
8. Durant le dernier mois, jusqu'à quel point avez-
vous eu de la difficulté à maintenir suffisamment 
d’enthousiasme pour compléter vos activités?     
9. Avez-vous un partenaire de lit ou de chambre?  
9.a Pas de partenaire de lit ou de chambre.  
9.b Partenaire ou colocataire dans une autre chambre.  
9.c Partenaire dans la même chambre, mais pas dans le même lit.  
9.d Partenaire dans le même lit.  
10. Si vous avez un partenaire de lit ou de chambre, 
demandez-lui combien de fois dans le dernier 
mois vous avez : 
Pas durant 
le dernier 
mois 
Moins 1 
fois par 
semaine 
1 ou 2 fois 
par 
semaine 
3 fois ou 
plus par 
semaine 
10.a Ronflé bruyamment?     
10.b Eu de longues pauses entre les respirations pendant 
votre sommeil? 
    
10.c Eu des contractions ou secousses dans les jambes 
pendant votre sommeil? 
    
10.d Eu des épisodes de désorientation ou de confusion 
durant le sommeil? 
    
10.e Eu des agitations pendant que vous dormiez? SVP 
décrire et à quelle fréquence? 
    
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1.2. Appendix II : Orthodontic Evaluation Form 
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FORMULAIRE D’ÉVALUATION
1. Physique  
1.a Origine : ______________________________ 
 
1.b  Hauteur : _______  + 100cm 
 
1.c  Poids : _________  lbs 
 
2.  Facial Convexe Droit Concave 
2.a Profil :    
  Brachy. Méso. Dolico. 
2.b Visage :    
  Fermé Normal Ouvert 
2.c FMA :    
 
2.d  Lignes médianes :  
  
  
 
3. Fonctionnel Buccale Nasale ½ : ½ 
3.a Respiration    
 
  Normales Grosses 
3.b Amygdales   
 
  Petite Normale Grosse Crénelée
3.c Langue     
 
 ATM Craquement Douleur Si Douleur, Combien? 
  Oui Non Oui Non 0 1 2 3 4 5 6 7 8 9 10
3.d Droite                
3.e Gauche                
 
  Normaux Anormaux 
3.f Mouvements Mand. Latéraux   
 
3.g  Overjet : _______ mm 
 
3.h  Overbite : ______  mm 
 
3.i  Ouverture Maximale (avec OB) : _______ mm 
 
4. Squelettique Diminué Normal Augmenté
4.a Transverse :     
4.b Vertical :     
4.c A-P :     
  Étroit Rond Plat 
4.d Palais    
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5. Dentaire 
 Classe I II III 
5.a Molaire Droite    
5.b Molaire Gauche    
5.c Canine Droite    
5.d Canine Gauche    
 
  Oui Non 
5.e Crossbite   
 (Si oui, encerclez les dents en crossbite) 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
 
 Chevauchement ou Espace Espace Chevauchement 
   Léger 
(1-2mm) 
Moyen 
(3-4mm) 
Sévère 
(>5mm) 
5.f Maxillaire     
5.g Mandibule     
 
 
 Attrition Non Émail  Dentine 
5.k Incisives Supérieures    
5.l Canines Supérieures    
5.m Prémolaires Supérieures    
5.n Molaires Supérieures    
5.o Incisives Inférieures    
5.p Canines Inférieures    
5.q Prémolaires Inférieures    
5.r Molaires Inférieures    
 
6. Tissus Mous 
6.a  Problèmes de paro.: ____________________________________________________ 
 
7. Diagnostique Classe I Classe II Classe III Autres 
7.a Dentaire     
7.b Squelettique     
 
  Non-Ex Exo P&I Exp. Chir. Autres 
8. Traitement 
Proposé 
      
 
  Accepté Refusé   AP HEK 
9. Cas    Évalué par   
 
 Courbes Légère Moyenne Sévère Inversée
5.h Spee     
5.i Monson     
5.j Wilson     
  
 
 
  
 
 
 
 
 
i
 
